|
EXOSC4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.369440E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.779700E-04 |
| Normal-vs-Stage2 |
1.261560E-03 |
| Normal-vs-Stage3 |
1.201310E-03 |
| Normal-vs-Stage4 |
5.672200E-02 |
| Stage1-vs-Stage2 |
9.109900E-02 |
| Stage1-vs-Stage3 |
6.906000E-01 |
| Stage1-vs-Stage4 |
4.119400E-01 |
| Stage2-vs-Stage3 |
1.535640E-01 |
| Stage2-vs-Stage4 |
4.325600E-02 |
| Stage3-vs-Stage4 |
3.009800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.246940E-04 |
| Normal-vs-AfricanAmerican |
5.473500E-02 |
| Normal-vs-Asian |
1.718460E-02 |
| Caucasian-vs-AfricanAmerican |
6.291400E-01 |
| Caucasian-vs-Asian |
5.619800E-01 |
| AfricanAmerican-vs-Asian |
9.574800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.676900E-03 |
| Normal-vs-Female |
1.768860E-04 |
| Male-vs-Female |
8.280200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.814100E-04 |
| Normal-vs-Age(41-60Yrs) |
4.597100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.823860E-03 |
| Normal-vs-Age(81-100Yrs) |
5.080000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.625000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.835600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.713200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.357200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.272600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.026800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.181800E-01 |
| Classical-VS-Follicular |
8.321800E-02 |
| Classical-VS-Other |
5.690400E-01 |
| Classical-VS-Normal |
5.359400E-03 |
| Tall-VS-Follicular |
1.730580E-01 |
| Tall-VS-Other |
4.807600E-01 |
| Tall-VS-Normal |
1.317450E-01 |
| Follicular-VS-Other |
9.110600E-01 |
| Follicular-VS-Normal |
2.354700E-04 |
| Other-VS-Normal |
5.678100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.21549999995996E-06 |
| Normal-vs-N1 |
1.793690E-02 |
| N0-vs-N1 |
6.440600E-01 |
|
|
